Ameritas Advisory Services LLC Sells 8,279 Shares of Haleon PLC Sponsored ADR $HLN

Ameritas Advisory Services LLC cut its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 44.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,246 shares of the company’s stock after selling 8,279 shares during the period. Ameritas Advisory Services LLC’s holdings in Haleon were worth $106,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in HLN. Brighton Jones LLC bought a new stake in Haleon in the 4th quarter worth about $187,000. Rhumbline Advisers grew its position in Haleon by 6.7% in the 1st quarter. Rhumbline Advisers now owns 57,527 shares of the company’s stock worth $592,000 after purchasing an additional 3,625 shares in the last quarter. Farther Finance Advisors LLC grew its position in Haleon by 8.8% in the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company’s stock worth $131,000 after purchasing an additional 1,041 shares in the last quarter. Simplicity Wealth LLC grew its position in Haleon by 7.9% in the 1st quarter. Simplicity Wealth LLC now owns 15,482 shares of the company’s stock worth $159,000 after purchasing an additional 1,135 shares in the last quarter. Finally, Fifth Third Bancorp grew its position in Haleon by 1.2% in the 1st quarter. Fifth Third Bancorp now owns 307,192 shares of the company’s stock worth $3,161,000 after purchasing an additional 3,643 shares in the last quarter. 6.67% of the stock is owned by institutional investors.

Haleon Stock Performance

Shares of HLN stock opened at $8.99 on Friday. The stock has a market capitalization of $40.03 billion, a P/E ratio of 23.04, a PEG ratio of 2.67 and a beta of 0.20. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The firm’s 50 day moving average is $9.42 and its 200 day moving average is $10.03. Haleon PLC Sponsored ADR has a 12 month low of $8.71 and a 12 month high of $11.42.

Haleon Increases Dividend

The company also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a $0.0555 dividend. The ex-dividend date was Friday, August 15th. This represents a yield of 190.0%. This is a boost from Haleon’s previous semi-annual dividend of $0.05. Haleon’s dividend payout ratio is currently 28.21%.

Wall Street Analysts Forecast Growth

HLN has been the subject of a number of recent analyst reports. The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. Barclays downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research report on Wednesday. Finally, Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.